CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market sale General Counsel sold 277 shares at $273.41 ($75,735)
- 4 Open-market sale Senior VP, Chief Pharma Dev. sold 442 shares at $273.41 ($120,847)
- 4 Open-market sale Pres., R&D, and CMO sold 1,689 shares at $273.41 ($461,789)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Open-market sale Director sold 3,600 shares at an average $315.31 ($1,135,122)
- 4 Open-market sale Director sold 3,400 shares at an average $350.30 ($1,191,028)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Commercial Officer sold 688 shares at $316.92 ($218,041)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale Director sold 5,000 shares at $350.00 ($1,750,000)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 5,000 shares at an average $300.94 ($1,504,703)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 11 of 62 · 1,224 filings